Join us for a conversation with Daniel S. Chen, MD, PhD, one of the leading voices in cancer immunotherapy. As the former Global Head of Cancer Immunotherapy Development at Genentech/Roche and current CEO of Synthetic Design Lab, Daniel shares lessons from developing groundbreaking therapies and his perspective on the future…
In this episode, Shareef Mahdavi explains why patient experience — not just clinical expertise — is the real driver behind growth. From increasing reviews from under 50 to more than 700, to nearly doubling monthly leads, Shareef shares how transforming the patient journey changed everything at Laser Eye Center of…
What if AI could completely change the way we understand disease and clinical trials? In this episode, we interview Dr. Joseph Geraci — mathematical physicist, AI researcher, and founder of NetraMark — about the future of explainable AI in medicine. Dr. Geraci’s background spans quantum computing, oncology, neuroscience, and machine…
Meet Gary K. Zammit—scientist, entrepreneur, and thought leader in the life sciences space. Gary is the founder and CEO of Clinilabs, a clinical research organization focused on CNS disorders, and the author of Beyond the Science. He is also a clinical professor of psychiatry at the Icahn School of Medicine…
In this episode, we bring together two outstanding leaders in clinical development to discuss the future of neuroscience and rare disease research. Joseph Grieco, VP and Head of Clinical Development at Tris Pharma, shares his experience leading innovative programs in neurological disorders, including pain, ADHD, opioid use disorder, and pediatric…
Meet Robert Packard, a medical device quality and regulatory expert with over 20 years of industry experience and 10+ years in biotech manufacturing. He’s led Quality and Regulatory Affairs at multiple startups, co-founded a laparoscopic imaging company, and served as a lead auditor and instructor for a major Notified Body.…
Discover how to successfully navigate the complex world of medical device regulations with Kristen Mittal, RAC, PMP — Co-Founder and CEO of Mittal Consulting. In this episode, Kristen shares insights from over a decade of experience working with startups and Fortune 500 companies, specializing in Class I, II, and III…
In this episode, we are joined by A/Prof Tina Soulis, a global leader in clinical research and biotechnology with over 30 years of experience across pharmaceuticals, medical devices, biotech, and academic research. Tina is the Founder and Director of Alithia Life Sciences, a full-service clinical CRO dedicated to advancing clinical…
In this episode, we’re joined by Gregory Mark Hill, Managing Partner at GCH Partners, who has spent more than 20 years working with entrepreneurs and growth-focused companies from New York to Silicon Valley and across international markets. Gregory shares insights from his experience in the world of capital, scaling businesses,…
In this episode, we sit down with physician, inventor, and serial entrepreneur David E. Albert, MD — a pioneer in digital cardiology who has spent more than three decades developing life-saving medical technologies that have transformed patient care. Dr. Albert is the founder of multiple health-tech companies and the creator…
In this episode, we’re joined by Alfonso, CEO at Leon Research and Managing Board Member at AICROS, to dive into leadership, growth, and innovation in clinical research. With 14 years of experience in executive and managerial roles—including over a decade in clinical investigation—Alfonso brings a unique, multidisciplinary perspective shaped by…
In this episode of Global Trial Accelerators, we sit down with Justin Chickles, CEO and co-founder of Glycyx Therapeutics, a clinical-stage biotech company taking on a hidden threat to cancer immunotherapy success: opioids. With over two decades of leadership across therapeutics, diagnostics, and digital health — including roles at Johnson…
In this episode, we welcome Steven Collens, CEO of MATTER, one of the world’s leading healthcare incubators and innovation hubs. Under Steven’s leadership, MATTER has supported more than 1,000 healthcare startups, helping innovators move faster, collaborate more effectively, and significantly improve their chances of success. MATTER works at the intersection…
In this episode, we welcome Pablo Yarza, a bioinformatics specialist with more than 15 years of experience developing advanced databases for academic and industrial use. Pablo shares his professional journey, the challenges of data curation in R&D environments, and how data quality issues can lead to costly delays in research…
In this episode, we welcome Scott Stout, a leader focused on transforming access to clinical trials through innovative provider engagement models. Through HCP Recruitment, Scott and the team at MedVector are redefining how clinical trial sites connect with patients by unlocking access to larger, more diverse populations. MedVector enables trusted…
In this episode, we welcome Matteo Talotta, a professional whose global and multidisciplinary background spans banking, academia, government, start-ups, scale-ups, and multinational corporations. Having worked across Canada, Italy, the United States, Spain, and Romania, Matteo brings a unique, firsthand perspective on the diverse challenges and opportunities within healthcare systems around…
In today’s episode, we sit down with Sonal Pendharkar Kulkarni, Ph.D., Co-founder and CSO of Uvisa Health. With expertise spanning women’s health, the microbiome, digital health, and medical device innovation, Sonal is leading groundbreaking work that aims to transform how vaginal health is understood and managed worldwide. She shares her…
In this episode, we sit down with David Kraemer, Founder of a boutique investment bank and former Vice President at Merrill Lynch and Wilshire Consulting. With deep experience across investment banking, venture capital, biotech, AI, and emerging technologies, David shares insights on capital formation, innovation, and navigating global markets. Tune…
In this episode, we sit down with Dr. Joseph M. Palumbo, a physician-scientist, mentor, and therapeutics developer with over three decades of leadership in psychiatry, neurology, and neurodegenerative research. Dr. Palumbo has held senior roles as Global Head of Psychiatry at Johnson & Johnson, Vice President & Fellow at Mitsubishi…
In this episode, we sit down with Dr. Joseph M. Palumbo, a physician-scientist, mentor, and therapeutics developer with over three decades of leadership in psychiatry, neurology, and neurodegenerative research. Dr. Palumbo has held senior roles as Global Head of Psychiatry at Johnson & Johnson, Vice President & Fellow at Mitsubishi…
In this episode, we sit down with Nicholas Kadysh, CEO of PharmAla Biotech, the company pioneering GMP MDMA production and recognized as the top-performing stock on the Canadian capital markets in 2023 by The Market Herald. As Chair of Psychedelics Canada, Nicholas has played a pivotal role in strengthening legal…
Carolina is a senior biotech executive with over 25 years of experience in the biopharmaceutical industry. She is the Founder & Principal of Bio Strategy Advisors, a strategic consulting firm specializing in start-up formation, corporate strategy, strategic partnerships, and global expansion. She currently serves on the boards of Syte.bio, Bonds…
In this episode, we welcome Dr. Jason Hurt, a clinician-scientist and entrepreneur with deep expertise in radiopharmaceutical development, clinical trial strategy, and oncology drug development. Dr. Hurt is the founder of Theragnostic Insights, a consulting and strategic advisory firm launched in March 2025 that is dedicated to advancing theranostic solutions…
In this episode, we talk with Dr. Martin R. Schiller, a renowned scientist, professor at UNLV, and founder of Heligenics Inc. Dr. Schiller shares his journey from academia to biotech entrepreneurship, his work leading the Nevada Institute of Personalized Medicine, and how his breakthrough technology, the GigaAssay, is transforming drug…